Free Trial

Cyclacel Pharmaceuticals (CYCC) Institutional Ownership

Cyclacel Pharmaceuticals logo
$0.35 -0.02 (-5.87%)
(As of 10:02 AM ET)

Institutional Ownership Changes (13F Filings) for Cyclacel Pharmaceuticals (NASDAQ:CYCC)

Current
Institutional Ownership
Percentage
23.58%
Number of
Institutional Buyers
(last 12 months)
1
Total
Institutional Inflows
(last 12 months)
$217.08K
Number of
Institutional Sellers
(last 12 months)
1
Total
Institutional Outflows
(last 12 months)
$20.97K
Get CYCC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cyclacel Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

CYCC Institutional Buying and Selling by Quarter

Cyclacel Pharmaceuticals Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
8/15/2024 Armistice Capital LLC134,000$217K0.0%N/A9.178%
5/10/2024 Acadian Asset Management LLC14,285$29K0.0%-41.0%1.084%
11/1/2022 Kestra Advisory Services LLC23,000$34K0.0%N/A0.183%
10/25/2022Raymond James Financial Services Advisors Inc.20,806$30K0.0%-32.5%0.166%
10/18/2022 McIlrath & Eck LLC26,342$38K0.0%N/A0.210%
8/15/2022 Sio Capital Management LLC454,355$491K0.2%+7.5%4.546%
2/10/2022 Acadian Asset Management LLC23,242$89K0.0%N/A0.233%
11/16/2021 Two Sigma Advisers LP121,500$640K0.0%+929.7%1.316%
11/15/2021 Pura Vida Investments LLC105,141$554K0.0%-33.2%1.139%
11/15/2021 Tri Locum Partners LP522,943$2.76M1.1%+66.9%5.663%
11/12/2021 Affinity Asset Advisors LLC400,000$2.11M0.5%+5.3%4.332%
11/2/2021Raymond James Financial Services Advisors Inc.10,006$53K0.0%-83.3%0.108%
10/15/2021NEXT Financial Group Inc14,752$77K0.0%+70.0%0.160%
8/18/2021 Ikarian Capital LLC100,000$593K0.0%-66.7%1.083%
8/17/2021 Boothbay Fund Management LLC10,545$62K0.0%-66.7%0.114%
8/17/2021 Citadel Advisors LLC250,797$1.49M0.0%-14.7%2.716%
8/16/2021 Tri Locum Partners LP313,331$1.86M0.6%+6.8%3.393%
8/16/2021 Schonfeld Strategic Advisors LLC102,525$607K0.0%-25.0%1.110%
8/16/2021 Maven Securities LTD234,500$1.43M0.1%-6.2%2.540%
8/13/2021 Northern Trust Corp14,957$89K0.0%N/A0.162%
8/13/2021 Geode Capital Management LLC50,860$301K0.0%+143.3%0.551%
8/13/2021 Vanguard Group Inc.327,658$1.94M0.0%+9.2%3.548%
7/31/2021NEXT Financial Group Inc8,680$51K0.0%N/A0.094%
5/19/2021Virtu Financial LLC13,108$93K0.0%+27.3%0.142%
5/19/2021 Squarepoint Ops LLC23,836$169K0.0%N/A0.258%
5/18/2021 Point72 Asset Management L.P.230,000$1.64M0.0%N/A2.491%
5/18/2021 Verition Fund Management LLC116,674$830K0.0%N/A1.264%
5/18/2021 Morgan Stanley100,000$711K0.0%-13.0%1.083%
5/18/2021 Citadel Advisors LLC293,867$2.09M0.0%N/A3.182%
5/18/2021 Silverarc Capital Management LLC250,000$1.78M1.0%N/A2.707%
5/17/2021 Schonfeld Strategic Advisors LLC136,725$972K0.0%N/A1.481%
5/17/2021 Sphera Funds Management LTD.508,322$3.61M0.3%N/A5.505%
5/17/2021 Ikarian Capital LLC300,000$2.13M0.1%-23.4%3.249%
5/12/2021 Geode Capital Management LLC20,904$148K0.0%N/A0.226%
5/12/2021 Pura Vida Investments LLC273,958$1.95M0.1%-42.3%2.967%
5/11/2021 Acadian Asset Management LLC34,057$242K0.0%N/A0.369%
4/12/2021 Valeo Financial Advisors LLC4,500$32K0.0%N/A0.063%
2/24/2021Virtu Financial LLC10,293$80K0.0%N/A0.212%
2/16/2021 Pura Vida Investments LLC475,000$3.71M0.1%N/A9.766%
2/16/2021 Acuta Capital Partners LLC150,000$1.17M0.3%N/A3.084%
2/12/2021Raymond James Financial Services Advisors Inc.57,006$445K0.0%+24.6%1.172%
2/12/2021 Ikarian Capital LLC391,450$3.06M0.1%N/A8.048%
11/4/2020Raymond James Financial Services Advisors Inc.45,756$167K0.0%+48.8%0.941%
(Data available from 1/1/2016 forward)

CYCC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of CYCC shares?

During the previous two years, the following institutional investors and hedge funds held shares of Cyclacel Pharmaceuticals shares: Armistice Capital LLC ($217K), Acadian Asset Management LLC ($29K).Learn more on CYCC's institutional investors.

What percentage of Cyclacel Pharmaceuticals stock is owned by institutional investors?

23.58% of Cyclacel Pharmaceuticals stock is owned by institutional investors. Learn more on CYCC's institutional investor holdings.

Which institutional investors have been buying Cyclacel Pharmaceuticals stock?

The following institutional investors have purchased Cyclacel Pharmaceuticals stock in the last 24 months: Armistice Capital LLC ($134K).

How much institutional buying is happening at Cyclacel Pharmaceuticals?

Institutional investors have bought a total of 134,000 shares in the last 24 months. This purchase volume represents approximately $217.08K in transactions.

Which Cyclacel Pharmaceuticals major shareholders have been selling company stock?

The following institutional investors have sold Cyclacel Pharmaceuticals stock in the last 24 months: Acadian Asset Management LLC ($9.94K).

How much institutional selling is happening at Cyclacel Pharmaceuticals?

Institutional investors have sold a total of 9,938 shares in the last 24 months. This volume of shares sold represents approximately $20.97K in transactions.



This page (NASDAQ:CYCC) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners